Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06685718. IPD Sharing: YES. Countries: 7. Publications: 0.
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02428855. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)
ClinicalTrials.gov study NCT00405054. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.
ClinicalTrials.gov study NCT01777776. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D
ClinicalTrials.gov study NCT01833143. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
ClinicalTrials.gov study NCT01436656. IPD Sharing: NO. Countries: 7. Publications: 0.
Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
ClinicalTrials.gov study NCT03898908. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT02012192. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
ClinicalTrials.gov study NCT03076164. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03292133. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03144804. IPD Sharing: NO. Countries: 1. Publications: 0.
Atezolizumab and Bevacizumab in EGFR Mutant NSCLC in Patients With Progressive Disease After Receiving Osimertinib
ClinicalTrials.gov study NCT04099836. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03704688. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
ClinicalTrials.gov study NCT03990896. IPD Sharing: YES. Countries: 1. Publications: 0.
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors
ClinicalTrials.gov study NCT03878095. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
ClinicalTrials.gov study NCT04655157. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC
ClinicalTrials.gov study NCT05987826. IPD Sharing: Not stated. Countries: 0. Publications: 44.
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
ClinicalTrials.gov study NCT06368934. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib
ClinicalTrials.gov study NCT01189435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data-driven models reveal mutant cell behaviors important for myxobacterial aggregation
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.